{"created":"2023-06-19T11:25:24.062876+00:00","id":6250,"links":{},"metadata":{"_buckets":{"deposit":"5946d1d0-1a9f-4055-b519-b6c0329bc381"},"_deposit":{"created_by":3,"id":"6250","owners":[3],"pid":{"revision_id":0,"type":"depid","value":"6250"},"status":"published"},"_oai":{"id":"oai:asahikawa-med.repo.nii.ac.jp:00006250","sets":["7","7:27:28"]},"author_link":["19648"],"item_6_alternative_title_3":{"attribute_name":"その他（別言語等）のタイトル","attribute_value_mlt":[{"subitem_alternative_title":"低酸素誘導因子はSGLT2阻害薬による糖尿病腎症治療標的である","subitem_alternative_title_language":"ja"}]},"item_6_biblio_info_21":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographic_titles":[{"bibliographic_title":"学位論文内容の要旨及び審査結果の要旨"}]}]},"item_6_description_28":{"attribute_name":"識別番号 その他","attribute_value_mlt":[{"subitem_description":"Scientific Reports, 2019;9:14754","subitem_description_type":"Other"},{"subitem_description":"PMID: 31611596","subitem_description_type":"Other"}]},"item_6_description_41":{"attribute_name":"フォーマット","attribute_value_mlt":[{"subitem_description":"application/pdf","subitem_description_type":"Other"}]},"item_6_text_7":{"attribute_name":"著者 ローマ字","attribute_value_mlt":[{"subitem_text_value":"Bessho, Ryoichi"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"別所, 瞭一"},{"creatorName":"ベッショ, リョウイチ","creatorNameLang":"ja-Kana"}],"nameIdentifiers":[{"nameIdentifier":"19648","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2021-07-06"}],"displaytype":"detail","filename":"7542.pdf","filesize":[{"value":"329.5 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"7542.pdf","url":"https://asahikawa-med.repo.nii.ac.jp/record/6250/files/7542.pdf"},"version_id":"8e0b491e-1fd4-4011-bb0d-0a83295238cb"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"旭川医科大学：博士（医学）（甲第543号）","subitem_subject_scheme":"Other"},{"subitem_subject":"学位授与年月日:令和2年3月25日","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"other","resourceuri":"http://purl.org/coar/resource_type/c_1843"}]},"item_title":"Hypoxia-inducible factor-1α is the therapeutic target od the SGLT2 inhibitor for diabetic nephropathy","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Hypoxia-inducible factor-1α is the therapeutic target od the SGLT2 inhibitor for diabetic nephropathy","subitem_title_language":"en"}]},"item_type_id":"6","owner":"3","path":["6","7","28"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2021-04-23"},"publish_date":"2021-04-23","publish_status":"0","recid":"6250","relation_version_is_last":true,"title":["Hypoxia-inducible factor-1α is the therapeutic target od the SGLT2 inhibitor for diabetic nephropathy"],"weko_creator_id":"3","weko_shared_id":-1},"updated":"2024-04-19T09:56:33.343918+00:00"}